News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Sanofi-Aventis (France) Seeks Acquisitions, Has $5.1 Billion in Cash
February 3, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Feb. 2 (Bloomberg) -- Sanofi-Aventis SA Chief Executive Officer Chris Viehbacher told employees France’s largest drugmaker has 4 billion euros ($5.1 billion) and is seeking acquisitions, a union representative said.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Europe
Sanofi
MORE ON THIS TOPIC
Mergers & acquisitions
Neurocrine Nabs Rare Obesity Disorder Drug in ‘Surprising’ $2.9B Soleno Deal
April 6, 2026
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
AI Giant Anthropic Leans Into Life Sciences With $400M Coefficient Bio Catch
April 6, 2026
·
2 min read
·
Tristan Manalac
Neurodegenerative diseases
Takeda Breaks Up With Denali, Dumps Dementia Drug
April 6, 2026
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Pharma’s M&A Train Is on Track for Record Highs With More Deals To Come: Analysts
April 3, 2026
·
3 min read
·
Annalee Armstrong